Cargando…
Novel Pathologic Factors for Risk Stratification of Gastric “Indefinite for Dysplasia” Lesions
METHODS: In total, 123 IND cases with final diagnoses of cancer (29.3%), high-grade dysplasia (6.5%), low-grade dysplasia (11.4%), and nonneoplasm (52.8%) were randomly divided into test set (n = 27) and validation set (n = 96). By the image analysis, size, pleomorphism, hyperchromasia, irregularity...
Autores principales: | Yim, Kwangil, Shin, Jung Ha, Yoo, Jinyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542492/ https://www.ncbi.nlm.nih.gov/pubmed/33061961 http://dx.doi.org/10.1155/2020/9460681 |
Ejemplares similares
-
Risk stratification of patients with gastric lesions indefinite for dysplasia
por: Cho, Young Sin, et al.
Publicado: (2021) -
Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors
por: Kwon, Mi Jung, et al.
Publicado: (2019) -
The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study
por: Phillips, Richard, et al.
Publicado: (2021) -
The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia
por: Januszewicz, Wladyslaw, et al.
Publicado: (2022) -
Combination of artificial intelligence‐based endoscopy and miR148a methylation for gastric indefinite dysplasia diagnosis
por: Watanabe, Yoshiyuki, et al.
Publicado: (2021)